/
ELOX
$17.25-$1.82 (-9.54%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$62.8M
3M shares
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-519.55
Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
www.eloxxpharma.com- Employees
- 7
- IPO / List date
- Dec 11, 1998
- HQ
- ARLINGTON, MA
Held by traders on TradeandTell
No one on the platform currently holds ELOX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ELOX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-06-01 | 1-for-11reverse |
| 2022-12-02 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded ELOX yet.
